Ocular Science

Manhattan Beach, United States

Ocular Science is a biotech company reducing dry eye and inflammation through post-operative care.

$16.5M raised

Jan 2026

Debt Financing

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Chicago Atlantic Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ocular Science

How much funding has Ocular Science raised?

Ocular Science has raised $16.5M in total funding. The most recent round was Debt Financing. The last funding was announced in January 2026.

Who are Ocular Science's investors?

Ocular Science's investors include Chicago Atlantic Group.

Where is Ocular Science headquartered?

Ocular Science is headquartered in Manhattan Beach, United States.

What does Ocular Science do?

Ocular Science is a biotech company reducing dry eye and inflammation through post-operative care.

What stage is Ocular Science at?

Ocular Science is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 15, 2026.

MLA

"Ocular Science — Funding & Investors." VCBacked, January 15, 2026, https://www.vcbacked.co/company/ocular-science. Accessed July 2, 2026.

APA

VCBacked. (2026). Ocular Science — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ocular-science

Wikipedia (cite web)

{{cite web |title=Ocular Science — Funding & Investors |url=https://www.vcbacked.co/company/ocular-science |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 15, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K